Table 3.
Linear regression for outcome eGFR at twelve months among those who did not reach the endpoint of ESRD by twelve months using focal as the reference group
| |
eGFR at 12 months (n = 57) |
|
|---|---|---|
| β | p-value | |
| eGFR at biopsy |
0.35 |
<0.001 |
| Age at biopsy (years) |
-0.52 |
0.003 |
| Crescentic class |
-11.35 |
0.092 |
| Mixed class |
-21.25 |
0.001 |
| Sclerotic class | -23.67 | 0.006 |